CMJAX
Price
$42.47
Change
+$0.22 (+0.52%)
Updated
Jul 16 closing price
Net Assets
457.23M
FSMDX
Price
$35.59
Change
+$0.18 (+0.51%)
Updated
Jul 16 closing price
Net Assets
42.38B
Interact to see
Advertisement

CMJAX vs FSMDX

Header iconCMJAX vs FSMDX Comparison
Open Charts CMJAX vs FSMDXBanner chart's image
Calvert US Mid Cap Core Rspnb Idx A
Price$42.47
Change+$0.22 (+0.52%)
VolumeN/A
Net Assets457.23M
Fidelity Mid Cap Index
Price$35.59
Change+$0.18 (+0.51%)
VolumeN/A
Net Assets42.38B
CMJAX vs FSMDX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CMJAX vs. FSMDX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMJAX is a Buy and FSMDX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 42.4B vs. CMJAX (457M). FSMDX pays higher dividends than CMJAX: FSMDX (1.31) vs CMJAX (0.87). CMJAX was incepted earlier than FSMDX: CMJAX (10 years) vs FSMDX (14 years). CMJAX (0.67) is less costly to investors than FSMDX (0.03). CMJAX is a more actively managed with annual turnover of: 28.00 vs. FSMDX (15.00). FSMDX has a lower initial minimum investment than CMJAX: FSMDX (0) vs CMJAX (5000). FSMDX annual gain was more profitable for investors over the last year : 8.58 vs. CMJAX (5.54). FSMDX return over 5 years is better than : 70.17 vs. CMJAX (55.79).
CMJAXFSMDXCMJAX / FSMDX
Total Expense Ratio0.490.031,960%
Annual Report Gross Expense Ratio0.670.032,680%
Fund Existence10 years14 years-
Gain YTD2.5735.11150%
Front Load5%N/A-
Min. Initial Investment50000-
Min. Initial Investment IRAN/AN/A-
Net Assets457M42.4B1%
Annual Yield % from dividends0.871.3166%
Returns for 1 year5.548.5865%
Returns for 3 years37.4745.9282%
Returns for 5 years55.7970.1780%
Returns for 10 yearsN/A117.56-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GROV1.510.08
+5.59%
Grove Collaborative Holdings
ANIK11.190.19
+1.73%
Anika Therapeutics
COMP6.580.10
+1.54%
Compass
BWA35.170.18
+0.51%
BorgWarner
ABLLL24.75-0.04
-0.16%
Abacus Global Management Inc. 9.875% Fixed Rate Senior Notes due 2028